文献速递主动脉外科

颈锁骨下动脉转位在2区TEVAR术中行左锁骨下动脉血运重建

Concomitant left subclavian artery revascularization with carotid-subclavian transposition during zone 2 thoracic endovascular aortic repair.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-04-03

本研究纳入2007至2018年58例接受2区胸主动脉腔内修复术(TEVAR)并行左锁骨下动脉转位的患者,主要观察不良事件。30天死亡率为5.2%,主要不良事件包括截瘫1.7%、短暂性轻瘫5.2%和卒中3.4%。多因素分析显示既往卒中是不良事件的独立预测因素。

要点

  • 颈锁骨下动脉转位是2区TEVAR术中左锁骨下动脉血运重建的安全有效方法。
  • 术后30天死亡率为5.2%,截瘫发生率1.7%,卒中发生率3.4%。
  • 既往卒中是术后不良事件的独立预测因素。

核心结论

  • 颈锁骨下动脉转位为2区TEVAR术中左锁骨下动脉血运重建提供了安全有效的方法,未增加手术风险且并发症率低。

研究设计与样本

  • 回顾性研究纳入2007至2018年所有接受2区TEVAR且未使用分支支架的患者。
  • 共58例患者接受左锁骨下动脉转位。

主要发现

  • 30天手术死亡3例(5.2%)。
  • 大多数患者手术时处于紧急(25例,43.1%)或急诊(12例,20.7%)状态。
  • TEVAR指征包括动脉瘤性疾病(34.5%)和B型主动脉夹层(慢性13.8%,急性51.7%)。
  • 主要不良事件包括截瘫1例(1.7%)、短暂性轻瘫3例(5.2%)和卒中2例(3.4%)。
  • 平均随访2.8年期间,死亡5例(8.6%)。

临床怎么用

  • 对于需要2区锚定区的TEVAR患者,可考虑采用颈锁骨下动脉转位进行左锁骨下动脉血运重建。
  • 术前应评估患者既往卒中史,以识别不良事件高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left subclavian revascularization has become an integral part of thoracic endovascular aortic repair to extend the proximal landing zone. This is most commonly achieved via carotid-subclavian bypass; however, this can be achieved via vessel transposition. METHODS: All patients who had zone 2 thoracic endovascular aortic repairs without branched grafts from 2007 to 2018 were included in the study. The primary outcomes were adverse events, including operative mortality, paraplegia, left arm ischemia, and stroke. Multivariable regression analysis was performed for baseline characteristics associated with adverse events. RESULTS: A total of 58 patients underwent left subclavian artery transposition for zone 2 thoracic endovascular aortic repair coverage. Operative (30-day) mortality occurred in 3 patients (5.2%). The majority of patients were operated on under urgent (N = 25; 43.1%) or emergency (N = 12; 20.7%) status. Indications for thoracic endovascular aortic repair included aneurysmal disease (34.5%) and type B aortic dissection (chronic [13.8%]; acute [51.7%]). Major adverse events included paraplegia (N = 1; 1.7%), transient paraparesis (N = 3; 5.2%), and stroke (N = 2; 3.4%). Over a mean follow-up of 2.8 years, there were 5 deaths (8.6%). On multivariable analysis, prior stroke (odds ratio, 31.4; 1.95-506.72; P = .02) was an independent predictor of adverse events. CONCLUSIONS: Carotid-subclavian transposition offers patients a safe and effective method for left subclavian artery revascularization during thoracic endovascular aortic repair with zone 2 coverage with no increased operative risk and a low complication rate.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bianco V, Sultan I, Kilic A, et al. Concomitant left subclavian artery revascularization with carotid-subclavian transposition during zone 2 thoracic endovascular aortic repair. J Thorac Cardiovasc Surg. 2019. PMID: 31030960. doi:10.1016/j.jtcvs.2019.03.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。